These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7863 related articles for article (PubMed ID: 1711933)

  • 1. Multivesicular liposomes containing bleomycin for subcutaneous administration.
    Roy R; Kim S
    Cancer Chemother Pharmacol; 1991; 28(2):105-8. PubMed ID: 1711933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivesicular liposomes containing 1-beta-D-arabinofuranosylcytosine for slow-release intrathecal therapy.
    Kim S; Kim DJ; Geyer MA; Howell SB
    Cancer Res; 1987 Aug; 47(15):3935-7. PubMed ID: 3607740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivesicular liposomes containing cytarabine for slow-release Sc administration.
    Kim S; Howell SB
    Cancer Treat Rep; 1987 May; 71(5):447-50. PubMed ID: 3567968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology.
    Angst MS; Drover DR
    Clin Pharmacokinet; 2006; 45(12):1153-76. PubMed ID: 17112293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization and performance evaluation of peptide-loaded monolithic poly-epsilon-caprolactone microspheres in mice bearing melanoma B16F1.
    Shenoy BD; Venkatesh M; Udupa N
    Pharmazie; 2002 Apr; 57(4):256-60. PubMed ID: 11998446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose bupivacaine remotely loaded into multivesicular liposomes demonstrates slow drug release without systemic toxic plasma concentrations after subcutaneous administration in humans.
    Davidson EM; Barenholz Y; Cohen R; Haroutiunian S; Kagan L; Ginosar Y
    Anesth Analg; 2010 Apr; 110(4):1018-23. PubMed ID: 20357145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleomycin A6-loaded anionic liposomes with in situ gel as a new antitumoral drug delivery system.
    Ding W; Li Y; Hou X; Li G
    Drug Deliv; 2016; 23(1):88-94. PubMed ID: 24845479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivesicular liposomes containing cytarabine entrapped in the presence of hydrochloric acid for intracavitary chemotherapy.
    Kim S; Howell SB
    Cancer Treat Rep; 1987; 71(7-8):705-11. PubMed ID: 3607782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation of plumbagin loaded long circulating pegylated liposomes: in vivo evaluation in C57BL/6J mice bearing B16F1 melanoma.
    Kumar MR; Aithal BK; Udupa N; Reddy MS; Raakesh V; Murthy RS; Raju DP; Rao BS
    Drug Deliv; 2011; 18(7):511-22. PubMed ID: 21793763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal bleomycin: increased therapeutic activity and decreased pulmonary toxicity in mice.
    Arndt D; Zeisig R; Bechtel D; Fichtner I
    Drug Deliv; 2001; 8(1):1-7. PubMed ID: 11280437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
    Allen TM; Mehra T; Hansen C; Chin YC
    Cancer Res; 1992 May; 52(9):2431-9. PubMed ID: 1568213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies.
    Gabizon A; Price DC; Huberty J; Bresalier RS; Papahadjopoulos D
    Cancer Res; 1990 Oct; 50(19):6371-8. PubMed ID: 1698120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct cerebrospinal fluid delivery of an antiretroviral agent using multivesicular liposomes.
    Kim S; Scheerer S; Geyer MA; Howell SB
    J Infect Dis; 1990 Sep; 162(3):750-2. PubMed ID: 2167343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity and antitumor activity of niosomal bleomycin in tumor bearing mice.
    Naresh RA; Udupa N; Devi PU
    Indian J Exp Biol; 1996 Aug; 34(8):764-72. PubMed ID: 8979482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic behavior of [57Co]bleomycin liposomes in mice: comparison with the unencapsulated substance.
    Fichtner I; Arndt D; Reszka R; Gens J
    Anticancer Drugs; 1991 Dec; 2(6):555-63. PubMed ID: 1725271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties.
    Krishna R; Webb MS; St Onge G; Mayer LD
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1206-12. PubMed ID: 11504822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliposomal Ropivacaine Oil: Pharmacokinetic and Pharmacodynamic Data After Subcutaneous Administration in Volunteers.
    Ginosar Y; Haroutounian S; Kagan L; Naveh M; Aharon A; Davidson EM
    Anesth Analg; 2016 May; 122(5):1673-80. PubMed ID: 27057798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits.
    Cabanes A; Reig F; Antón JM; Arboix M
    Am J Vet Res; 1995 Nov; 56(11):1498-501. PubMed ID: 8585663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depot characteristics and biodistribution of interleukin-2 liposomes: importance of route of administration.
    Anderson PM; Katsanis E; Sencer SF; Hasz D; Ochoa AC; Bostrom B
    J Immunother (1991); 1992 Jul; 12(1):19-31. PubMed ID: 1637781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivesicular liposome formulations for the sustained delivery of interferon alpha-2b.
    Qiu J; Wei XH; Geng F; Liu R; Zhang JW; Xu YH
    Acta Pharmacol Sin; 2005 Nov; 26(11):1395-401. PubMed ID: 16225764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 394.